yttrium radioisotopes has been researched along with Lymph Node Metastasis in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Frey, G; Jia, Z; McKinney, JM; Paz-Fumagalli, R; Sella, DM; Wang, W | 1 |
Bencze, A; Igaz, P; Leiszter, K; Nagy, Z; Patócs, A; Rácz, K; Szücs, N | 1 |
Bugiantella, W; Carnelutti, A; Leo, CA; Lorenzin, D; Pravisani, R; Risaliti, A; Soardo, G; Umberto, B | 1 |
Campbell, J; Gates, VL; Ho, CL; Lewandowski, RJ; Qing, F; Salem, R; Savin, M; Tang, B; Thie, J; Wong, CY | 1 |
Baete, K; Deroose, CM; Haustermans, K; Koole, M; Mortelmans, L; Mottaghy, FM; Terwinghe, C; Van Binnebeek, S; Van Cutsem, E; Vanbilloen, B; Verbruggen, A; Verslype, C | 1 |
Ahmadi, MA; Esmaeli, B; McLaughlin, P; Murray, JL; Naderi, A; Romaguera, J; Singh, S; White, CA | 1 |
Dworkin, HJ; Gates, VL; Raman, S; Salem, R; Wong, CY | 1 |
1 trial(s) available for yttrium radioisotopes and Lymph Node Metastasis
Article | Year |
---|---|
Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Microspheres; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2002 |
6 other study(ies) available for yttrium radioisotopes and Lymph Node Metastasis
Article | Year |
---|---|
Single-institution experience of radioembolization with yttrium-90 microspheres for unresectable metastatic neuroendocrine liver tumors.
Topics: Aged; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Microspheres; Middle Aged; Neuroendocrine Tumors; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Yttrium Radioisotopes | 2017 |
[Carcinoid heart disease].
Topics: Carcinoid Heart Disease; Diagnosis, Differential; Echocardiography, Doppler, Color; Flushing; Humans; Ileal Neoplasms; Lymphatic Metastasis; Male; Malignant Carcinoid Syndrome; Middle Aged; Octreotide; Prognosis; Radiotherapy, Adjuvant; Severity of Illness Index; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2013 |
Complete Remission of Unresectable Hepatocellular Carcinoma After Combined Sorafenib and Adjuvant Yttrium-90 Radioembolization.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoradiotherapy; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Niacinamide; Phenylurea Compounds; Portal Vein; Radiopharmaceuticals; Radiotherapy, Adjuvant; Remission Induction; Sorafenib; Thrombosis; Treatment Outcome; Yttrium Radioisotopes | 2016 |
Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography predicts extrahepatic metastatic potential of colorectal metastasis: a practical guide for yttrium-90 microsphere liver-directed therapy.
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tissue Distribution; Tomography, X-Ray Computed; Tumor Cells, Cultured; Yttrium Radioisotopes | 2010 |
Altered biodistribution of somatostatin analogues after first cycle of Peptide receptor radionuclide therapy.
Topics: Adult; Disease Progression; Female; Humans; Indium Radioisotopes; Intestinal Neoplasms; Liver Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Positron-Emission Tomography; Radioisotopes; Receptors, Peptide; Somatostatin; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2011 |
Immunotherapy for low-grade non-hodgkin secondary lymphoma of the orbit.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Female; Humans; Immunotherapy; Lymphatic Metastasis; Lymphoma, B-Cell; Male; Orbital Neoplasms; Rituximab; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2002 |